The white paper recommends extending endoscopic classification of gastroesophageal junction integrity beyond the slope.

Published Date: 08 Mar 2023

A new white paper from the American Foregut Society expands gastrointestinal tract (EGJ) classification, including axial hiatal hernia length, hiatal hernia opening diameter, ...

Read Full News

Latest News

Why the Painless Abdominal Bloating in Middle-Age Man?

Admitted for pyelonephritis, but his diagnostic journey is just beginning

Beware Aspiration Risk in Chronic Pot Users

A cautionary tale of gastroparesis-related aspiration in NPO patient with no other risk factors

Unusual Confluence of Two Rare Syndromes Results in Peculiar Symptoms

Interpretation of an ultrasound exam made all the difference in creating a treatment plan

Common Meds Linked to Reduced Immunotherapy Benefit in Lung Cancer Trial

— Results highlight importance of careful evaluation of concurrent medications, researchers say

Q&A: Managing GI Toxicities of Immunotherapy

Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Latest News

Admitted for pyelonephritis, but his diagnostic journey is just beginning

A cautionary tale of gastroparesis-related aspiration in NPO patient with no other risk factors

Interpretation of an ultrasound exam made all the difference in creating a treatment plan

— Results highlight importance of careful evaluation of concurrent medications, researchers say

Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

News All Time

Enhanced MRI Tops Ultrasound in Catching Early Liver Cancer

MRI approach also led to fewer false referrals

Multicancer Early Detection Test Fails to Reduce Cancers Detected at Late Stages

However, an increase in the detection of stage I/II cancers was observed

'A Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

RASolute 302 findings herald a new standard of care in previously treated patients

Albumin 5% Cut Mortality Rates in Sudden Liver Failure With Other Organ Failure

Treatment may be an effective bridge to transplantation for acute-on-chronic liver failure

Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis

More than half of patients saw a biochemical response by 1 year with the novel oral agent

Targeted Combo Boosts PFS in BRAF-Mutant Metastatic Colorectal Cancer

Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival

Non-Operative Treatment for CRC May Include Observation After Complete Response

No difference in disease-free, overall survival compared with 3 years of maintenance therapy

Adding Immunotherapy-Based Combo Boosts PFS in Unresectable Liver Cancer

But is the higher incidence of grade 3/4 adverse events "a worthwhile price to pay?" expert asks

Large Study Links GLP-1s to Lower Risk of Multiple Cancers

Patients taking the drugs for obesity had a 41% lower risk of related cancers

Fart Frequency in Men vs Women; Organ Transplant in Celiacs; Engineered Gut Bacteria

News and commentary from the world of gastroenterology and hepatology

Study Warns on Sugary Drinks and Liver Cancer

However, no association between artificially sweetened drinks and liver cancer observed

Tolerability Concerns for GLP-1/Glucagon Agonist in Obesity, MASLD

Roughly one in five patients ditched survodutide due to adverse events

NICU Babies More Likely to Miss Rotavirus Vax

Study shows impact of guidelines' strict upper age limit and suggestion of delay until discharge

Gas-X Recall; MASLD and Alzheimer's Mortality; Counties Without a Gastroenterologist

News and commentary from the world of gastroenterology and hepatology

Study Linking Vaccines to Autism Retracted

Research was included in CDC's recent hepatitis B birth vaccination review

Study Flags Overuse of Antibiotics for Diverticulitis

Guidelines call for selective use in uncomplicated cases, but that's not happening at the VA

Recommended News For You

Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer

Study finds that AI is better at forecasting the risk of developing cancer.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

unhealthy sleeping habits and the risk of esophageal adenocarcinoma.

Psychiatric Disorders Are Common in Dementia Patients.

Novel probes to label macrophages associated with cancer progression using a selective dye

Recommended Articles For You

Uncovering the Mystery of Burkitt's Lymphoma: A New Hope for Treatment 

Virtual Survivorship Platforms in Cancer Care: Transforming Post-Treatment Support and Outcomes 

Adaptive Neoantigen Vaccines for Solid Tumor Therapy 

Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

2.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

3.

healthy despite having advanced cancer.

4.

Breast awareness: What to look for in your self-exam

5.

Significant differences in breast cancer care still exist, but surgeons can change.

1.

The Genetics of Bernard Soulier Syndrome: What We Know so Far

2.

Modern Perspectives in Hematology for Modern Medicine

3.

Everything You Need to Know About the Latest Hyponatremia Algorithm 

4.

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways

5.

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

2.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

4.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot